• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子受体(TNFR)家族的共刺激成员:有效T细胞免疫的关键?

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

作者信息

Croft Michael

机构信息

Division of Molecular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA.

出版信息

Nat Rev Immunol. 2003 Aug;3(8):609-20. doi: 10.1038/nri1148.

DOI:10.1038/nri1148
PMID:12974476
Abstract

Interactions between co-stimulatory ligands and their receptors are crucial for the activation of T cells, the prevention of tolerance and the development of T-cell immunity. It is now evident that members of the immunoglobulin-like CD28-B7 co-stimulatory family cannot fully account for an effective long-lasting T-cell response or the generation of memory T cells. Several members of the tumour-necrosis factor receptor (TNFR) superfamily--OX40, 4-1BB, CD27, CD30 and HVEM (herpes-virus entry mediator)--are poised to deliver co-stimulatory signals both early and late after encounter with antigen. The roles of these molecules in initiating and sustaining the T-cell response and in promoting long-lived immunity are discussed.

摘要

共刺激配体与其受体之间的相互作用对于T细胞的激活、耐受性的预防以及T细胞免疫的发展至关重要。现在很明显,免疫球蛋白样CD28 - B7共刺激家族的成员不能完全解释有效的持久T细胞反应或记忆T细胞的产生。肿瘤坏死因子受体(TNFR)超家族的几个成员——OX40、4 - 1BB、CD27、CD30和疱疹病毒进入介质(HVEM)——在遇到抗原后的早期和晚期都准备好传递共刺激信号。本文讨论了这些分子在启动和维持T细胞反应以及促进长期免疫中的作用。

相似文献

1
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?肿瘤坏死因子受体(TNFR)家族的共刺激成员:有效T细胞免疫的关键?
Nat Rev Immunol. 2003 Aug;3(8):609-20. doi: 10.1038/nri1148.
2
TNF/TNFR family members in costimulation of T cell responses.肿瘤坏死因子/肿瘤坏死因子受体家族成员在T细胞反应共刺激中的作用
Annu Rev Immunol. 2005;23:23-68. doi: 10.1146/annurev.immunol.23.021704.115839.
3
Role of T cell costimulation in anti-viral immunity.T细胞共刺激在抗病毒免疫中的作用。
Semin Immunol. 2004 Jun;16(3):185-96. doi: 10.1016/j.smim.2004.02.006.
4
Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.CD30/CD153而非CD27/CD70、CD134/OX40L或CD137/4-1BBL对鸟分枝杆菌保护性免疫的最佳诱导作用。
J Leukoc Biol. 2004 Nov;76(5):1039-46. doi: 10.1189/jlb.1103572. Epub 2004 Aug 17.
5
4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.4-1BB和OX40刺激增强CD8和CD4 T细胞对DNA初免、痘病毒加强疫苗的反应。
Immunology. 2004 Aug;112(4):559-66. doi: 10.1111/j.1365-2567.2004.01917.x.
6
A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.CD28与肿瘤坏死因子受体家族成员B和T淋巴细胞衰减器以及疱疹病毒进入介质之间的共受体相互作用。
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1116-21. doi: 10.1073/pnas.0409071102. Epub 2005 Jan 12.
7
Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.针对肿瘤坏死因子受体超家族新成员TR2(疱疹病毒进入介质)的抗体可阻断T细胞增殖、激活标志物的表达以及细胞因子的产生。
J Immunol. 1998 Aug 15;161(4):1786-94.
8
Role of 4-1BB in immune responses.4-1BB在免疫反应中的作用。
Semin Immunol. 1998 Dec;10(6):481-9. doi: 10.1006/smim.1998.0157.
9
Regulation of immune responses by the ligands for CD27, CD30, and 4-1BB.CD27、CD30和4-1BB配体对免疫反应的调节。
Circ Shock. 1994 Oct;44(2):73-6.
10
[Lymphocyte coreceptors].[淋巴细胞共受体]
Med Sci (Paris). 2006 Dec;22(12):1069-74. doi: 10.1051/medsci/200622121069.

引用本文的文献

1
Synergy of oncolytic adenovirus and immune checkpoint inhibitors: transforming cancer immunotherapy paradigms.溶瘤腺病毒与免疫检查点抑制剂的协同作用:转变癌症免疫治疗模式
Front Immunol. 2025 Jul 8;16:1610858. doi: 10.3389/fimmu.2025.1610858. eCollection 2025.
2
Efficacy of Using Dendritic Cells in the Treatment of Prostate Cancer: A Systematic Review.使用树突状细胞治疗前列腺癌的疗效:一项系统评价
Int J Mol Sci. 2025 May 21;26(10):4939. doi: 10.3390/ijms26104939.
3
OX40/OX40L as a Therapeutic Target in Atopic Dermatitis: A Scoping Review.
OX40/OX40L作为特应性皮炎的治疗靶点:一项范围综述
Biologics. 2025 May 2;19:281-288. doi: 10.2147/BTT.S511125. eCollection 2025.
4
PILRα on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunity.肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用,以抑制抗肿瘤免疫。
Nat Cancer. 2025 May 1. doi: 10.1038/s43018-025-00958-7.
5
Network pharmacology and in silico analysis reveal Kochiae Fructus as a potential therapeutic against atopic dermatitis through immunomodulatory pathway interactions.网络药理学和计算机模拟分析表明,地肤子通过免疫调节途径相互作用,是治疗特应性皮炎的一种潜在药物。
PLoS One. 2025 Apr 3;20(4):e0320818. doi: 10.1371/journal.pone.0320818. eCollection 2025.
6
Enhanced durability of a Zika virus self-amplifying RNA vaccine through combinatorial OX40 and 4-1BB agonism.通过联合使用OX40和4-1BB激动剂增强寨卡病毒自我扩增RNA疫苗的耐久性
JCI Insight. 2025 Apr 3;10(10). doi: 10.1172/jci.insight.187405. eCollection 2025 May 22.
7
MD Simulation Reveals a Trimerization-Enhanced Interaction of CD137L with CD137.分子动力学模拟揭示了CD137L与CD137三聚化增强的相互作用。
Int J Mol Sci. 2025 Feb 22;26(5):1903. doi: 10.3390/ijms26051903.
8
MiR-125b-5p ameliorates ox-LDL-induced vascular endothelial cell dysfunction by negatively regulating TNFSF4/TLR4/NF-κB signaling.微小RNA-125b-5p通过负向调节肿瘤坏死因子超家族成员4/ Toll样受体4/核因子κB信号通路改善氧化型低密度脂蛋白诱导的血管内皮细胞功能障碍。
BMC Biotechnol. 2025 Jan 24;25(1):11. doi: 10.1186/s12896-025-00944-y.
9
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy.从体外到体内嵌合抗原T细胞制造:基于CAR-T细胞疗法的新视野
J Transl Med. 2025 Jan 4;23(1):10. doi: 10.1186/s12967-024-06052-3.
10
Comparison of CD30L and OX40L Reveals CD30L as a Promising Therapeutic Target in Atopic Dermatitis.CD30L与OX40L的比较显示CD30L是特应性皮炎中一个有前景的治疗靶点。
Allergy. 2025 Feb;80(2):500-512. doi: 10.1111/all.16412. Epub 2024 Nov 26.